Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Researchers combine genetic and clinical factors in new VTE risk score

Key clinical point: A genetic and clinical risk factor score may offer a better way to predict venous thromboembolism risk in patients with lymphoma.

Major finding: The TiC-Lympho score for venous thromboembolism risk among lymphoma patients had a sensitivity of 93.55% and a specificity of 54.49%.

Study details: A retrospective study in 208 patients with lymphoma.

Disclosures: No conflicts of interest were reported.


Pascual C et al. 2019 ISTH Congress, Abstract OC 41.3.